血脂异常是女性甲状腺功能减退症的危险因素:一项来自韩国的纵向队列研究
该研究对1665名韩国成年人进行回顾性纵向队列分析,中位随访61.0个月,发现24.3%发生甲状腺功能减退症。
要点
- 女性基线血脂异常与甲状腺功能减退症风险升高独立相关(校正HR=2.05)。
- 女性血脂异常与严重亚临床甲状腺功能减退症或临床甲状腺功能减退症风险升高相关(校正HR=5.33)。
- 男性血脂异常与甲状腺功能减退症无显著关联(校正HR=1.00)。
核心结论
- 在韩国成年人中,血脂异常与女性甲状腺功能减退症的发生相关,但男性中无此关联。
- 作者指出该发现需要进一步确认。
研究设计与样本
- 回顾性分析纵向队列研究数据,纳入接受医学检查且至少进行4次甲状腺功能生化评估的韩国成年人1665名。
- 主要结局为甲状腺功能减退症(促甲状腺激素>4.2 mU/L),次要结局为严重亚临床甲状腺功能减退症(促甲状腺激素≥10.0 mU/L且游离甲状腺素正常)或临床甲状腺功能减退症(总三碘甲状腺原氨酸<80 ng/dL和/或游离甲状腺素<0.93 ng/dL且促甲状腺激素升高)。
主要发现
- 中位随访61.0个月期间,24.3%(404/1665)的个体发生甲状腺功能减退症,其中36名(2.1%)为严重亚临床甲状腺功能减退症或临床甲状腺功能减退症。
- 排除末次随访时首次出现促甲状腺激素异常的患者后,44.5%(126/283)的甲状腺功能减退症患者促甲状腺激素自发正常化。
关键数值与推荐
- 甲状腺功能减退症定义为促甲状腺激素>4.2 mU/L。
- 严重亚临床甲状腺功能减退症定义为促甲状腺激素≥10.0 mU/L且游离甲状腺素正常。
- 临床甲状腺功能减退症定义为总三碘甲状腺原氨酸<80 ng/dL和/或游离甲状腺素<0.93 ng/dL且促甲状腺激素升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出该发现需要进一步确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Hypothyroidism is a risk factor for dyslipidemia. We explored whether dyslipidemia is a risk factor for hypothyroidism. Methods: We performed a retrospective analysis of data from a longitudinal cohort study of South Korean adults who underwent medical examination and ≥4 biochemical assessments of thyroid function. The primary outcome was hypothyroidism (thyrotropin [TSH] >4.2 mU/L), and the secondary outcome was severe subclinical hypothyroidism (SCH; TSH ≥10.0 mU/L and normal free thyroxine [fT4] level) or overt hypothyroidism (OH; total triiodothyronine <80 ng/dL and/or fT4 < 0.93 ng/dL and high TSH values). The association of baseline dyslipidemia status with subsequent hypothyroidism was evaluated using Kaplan-Meier curves with the log-rank test and Cox proportional hazards regression models (for the entire population and respective genders). Subgroup analyses according to age (<40 and ≥40 years) and body-mass index (BMI; <23, 23-25, and ≥25 kg/m2) were performed according to gender. Results: We included 1665 participants. During a median follow-up period of 61.0 months, 24.3% (404/1665) individuals developed hypothyroidism. Among these, 36 participants (2.1%) had severe SCH or OH. Excluding patients with a first abnormal TSH level at last follow-up, 44.5% (126/283) of the patients with hypothyroidism had spontaneous TSH normalization. In respective multivariate analyses, dyslipidemia at baseline was independently associated with development of hypothyroidism in women (adjusted hazard ratio [HR] = 2.05 [1.31-3.19], p = 0.002), but not in men (adjusted HR = 1.00 [0.77-1.30], p = 0.991). In women, the presence of dyslipidemia at baseline was associated with development of severe SCH or OH (adjusted HR = 5.33 [1.41-20.12], p = 0.014). In women, respective associations according to age and BMI were as follows: age <40 years, adjusted HR = 2.90 (1.34-6.26, p = 0.007); age ≥40 years, adjusted HR = 1.85 (1.08-3.14, p = 0.023); BMI <23 kg/m2, adjusted HR = 1.68 (0.82-3.43, p = 0.151); BMI = 23-25 kg/m2, adjusted HR = 2.17 (0.93-5.07, p = 0.071); and BMI ≥25 kg/m2, adjusted HR = 2.82 (1.16-6.86, p = 0.022). Conclusions: In Korean adults, dyslipidemia was associated with development of hypothyroidism in women. Our findings require confirmation.
引用
- Kim HI, Kim TH, Kim H, et al. Dyslipidemia Is a Risk Factor for Hypothyroidism in Women: A Longitudinal Cohort Study from South Korea. Thyroid. 2023. PMID: 36602760. doi:10.1089/thy.2022.0216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。